The protein debate: optimal intake, limitations of the RDA, whether high-protein intake is harmful, and how to think about processed foods | David Allison, Ph.D.

Peter Attia

Oct 13, 2025

Episode description

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

David Allison is a world-renowned scientist and award-winning scientific writer who has spent more than two decades at the forefront of obesity research. In this episode, David joins for his third appearance on The Drive to bring clarity to one of the most contentious topics in modern nutrition—protein. He explores the historical pattern of demonizing macronutrients, the origins and limitations of the RDA for protein, and what the evidence really says about higher protein intake, muscle protein synthesis, and whether concerns about harm are supported by actual data. He also discusses the challenges of conducting rigorous nutrition studies, including the limits of epidemiology and crossover designs, as well as conflicts of interest in nutrition science and why transparency around data, methods, and logic matter more than funding sources. The episode closes with a discussion on processed and ultra-processed foods, the public health challenges of tackling obesity, and whether future solutions may depend more on drugs like GLP-1 agonists or broader societal changes. This is part one of a two-part deep dive on protein, setting the stage for next week’s conversation with Rhonda Patrick.

We discuss:

The cyclical pattern of demonizing different macronutrients in nutrition and why protein has recently become the latest target of controversy [3:15];
The origin and limits of the protein RDA: from survival thresholds to modern optimization [6:30];
Trust vs. trustworthiness: why data, methods, and logic matter more than motives in science [13:30];
The challenges of nutrition science: methodological limits, emotional bias, and the path to honest progress [17:15];
Why the protein RDA is largely inadequate for most people, and the lack of human evidence that high protein intake is harmful [30:30];
Understanding the dose-response curve for muscle protein synthesis as protein intake increases [45:15];
Why nutrition trials are chronically underpowered due to weak economic incentives, and how this skews evidence quality and perceptions of conflict [48:15];
The limitations and biases of nutrition epidemiology, and the potential role of AI-assisted review to improve it [56:15];
The

Mindsip insights from this episode:

Reassess public health strategies to combat obesity crisis

After 50 years of effort, traditional public health solutions like school-based programs and menu labeling have failed to produce any palpable or demonstrable success against obesity.

#obesity

Aim higher than RDA for protein to thrive

With rare exceptions, almost no one should aim for the RDA of protein (0.8g/kg), as this is a standard for mere survival, not for thriving or optimization.

#nutrition

#protein

Aim for 2 grams of protein per kilogram for optimal health

For optimal health, strength, and longevity goals, a good target is to consume around 2 grams of protein per kilogram of body weight daily, spaced throughout the day.

#longevity

#protein

Debunk myths: Higher protein intake shows no harm to health outcomes

There are no human intervention studies showing that higher protein intake causes deleterious effects on clinically meaningful outcomes like heart attacks, strokes, or death.

#protein

Rethink ultra-processed food classification for health insights

The concept of 'ultra-processed food' is not a meaningful scientific category for determining health effects, as a substance's impact depends on its molecular structure, not its ancestry or processing.

#processed-food

Consider pharmacological drugs as standard for obesity management

The future of managing obesity may involve the default use of pharmacological drugs like GLP-1 agonists for the general population, similar to how vaccines are administered.

#GLP1

#obesity

Focus critiques on data, methods, and logic, not funding sources

When evaluating scientific claims, the data, methods, and logic are what matter, and critiques should focus on these rather than resorting to ad hominem attacks about funding sources.

#research

Advocate for increased funding in nutrition research

Nutrition research is severely underfunded compared to pharmaceuticals because basic foods cannot be patented, which prevents the massive economic investment required for large, rigorous trials.

#nutrition

#research

Peter Attia

#399 ‒ The evolution of Alzheimer's disease and dementia care: how early detection, personalized treatment, new therapies, and a multimodal approach are changing the landscape | Gayatri Devi, M.D.

Building strength and muscle mass: how to optimize training, nutrition, and more for longevity (AMA #71 rebroadcast)

#398 ‒ AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss

#397 ‒ Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, and emerging treatments | Renato Tomioka, M.D., Ph.D.

#396 ‒ Breast cancer screening: understanding risk, deciding when to start and how often to screen, and choosing the right imaging strategy